| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | RCC1 | 2.05e-04 | 20 | 20 | 2 | PF00415 | |
| Domain | RCC1_3 | 2.26e-04 | 21 | 20 | 2 | PS50012 | |
| Domain | RCC1_1 | 2.26e-04 | 21 | 20 | 2 | PS00625 | |
| Domain | RCC1_2 | 2.26e-04 | 21 | 20 | 2 | PS00626 | |
| Domain | Reg_chr_condens | 2.48e-04 | 22 | 20 | 2 | IPR000408 | |
| Domain | - | 2.48e-04 | 22 | 20 | 2 | 2.130.10.30 | |
| Domain | RCC1/BLIP-II | 2.72e-04 | 23 | 20 | 2 | IPR009091 | |
| Domain | SPRY | 3.86e-03 | 87 | 20 | 2 | SM00449 | |
| Domain | SPRY | 4.49e-03 | 94 | 20 | 2 | PF00622 | |
| Domain | SPRY_dom | 4.49e-03 | 94 | 20 | 2 | IPR003877 | |
| Domain | B30.2/SPRY | 4.58e-03 | 95 | 20 | 2 | IPR001870 | |
| Domain | B302_SPRY | 4.58e-03 | 95 | 20 | 2 | PS50188 | |
| Domain | ARM-type_fold | 5.37e-03 | 339 | 20 | 3 | IPR016024 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 1.46e-04 | 612 | 13 | 5 | MM15547 | |
| Pubmed | 3.75e-09 | 653 | 22 | 8 | 22586326 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 5.66e-09 | 1024 | 22 | 9 | 24711643 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.41e-08 | 774 | 22 | 8 | 15302935 | |
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 2.35e-07 | 85 | 22 | 4 | 16051665 | |
| Pubmed | 7.65e-07 | 114 | 22 | 4 | 31553912 | ||
| Pubmed | 1.52e-06 | 1429 | 22 | 8 | 35140242 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 5.86e-06 | 759 | 22 | 6 | 35915203 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 6.29e-06 | 1203 | 22 | 7 | 29180619 | |
| Pubmed | 7.44e-06 | 202 | 22 | 4 | 24639526 | ||
| Pubmed | 7.87e-06 | 451 | 22 | 5 | 30033366 | ||
| Pubmed | 9.35e-06 | 65 | 22 | 3 | 28276505 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 25460509 | ||
| Pubmed | 1.33e-05 | 503 | 22 | 5 | 16964243 | ||
| Pubmed | 1.57e-05 | 244 | 22 | 4 | 29884807 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.76e-05 | 533 | 22 | 5 | 30554943 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.89e-05 | 1425 | 22 | 7 | 30948266 | |
| Pubmed | 2.03e-05 | 549 | 22 | 5 | 38280479 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.15e-05 | 954 | 22 | 6 | 36373674 | |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 2.72e-05 | 281 | 22 | 4 | 30455355 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 3.23e-05 | 605 | 22 | 5 | 28977666 | |
| Pubmed | Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients. | 3.46e-05 | 14 | 22 | 2 | 28878358 | |
| Pubmed | 4.88e-05 | 660 | 22 | 5 | 32780723 | ||
| Pubmed | 5.21e-05 | 332 | 22 | 4 | 25693804 | ||
| Pubmed | 5.71e-05 | 340 | 22 | 4 | 29478914 | ||
| Pubmed | 7.63e-05 | 131 | 22 | 3 | 35356984 | ||
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 9.10e-05 | 139 | 22 | 3 | 25476789 | |
| Pubmed | 9.56e-05 | 1247 | 22 | 6 | 27684187 | ||
| Pubmed | TRIM11 activates the proteasome and promotes overall protein degradation by regulating USP14. | 9.59e-05 | 23 | 22 | 2 | 29581427 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.10e-04 | 148 | 22 | 3 | 32538781 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 1.12e-04 | 1284 | 22 | 6 | 17353931 | |
| Pubmed | 1.27e-04 | 418 | 22 | 4 | 34709266 | ||
| Pubmed | 1.27e-04 | 809 | 22 | 5 | 32129710 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.30e-04 | 1318 | 22 | 6 | 30463901 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.50e-04 | 1353 | 22 | 6 | 29467282 | |
| Pubmed | 1.58e-04 | 847 | 22 | 5 | 35850772 | ||
| Pubmed | A neurogenomics approach to gene expression analysis in the developing brain. | 1.65e-04 | 170 | 22 | 3 | 15582152 | |
| Pubmed | The sperm-associated antigen 6 interactome and its role in spermatogenesis. | 2.62e-04 | 199 | 22 | 3 | 31146259 | |
| Pubmed | 2.98e-04 | 971 | 22 | 5 | 33306668 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 3.24e-04 | 989 | 22 | 5 | 36424410 | |
| Pubmed | 3.29e-04 | 215 | 22 | 3 | 30462309 | ||
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 3.40e-04 | 43 | 22 | 2 | 34672947 | |
| Pubmed | 3.63e-04 | 1014 | 22 | 5 | 32416067 | ||
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 4.06e-04 | 231 | 22 | 3 | 36597993 | |
| Pubmed | 4.21e-04 | 234 | 22 | 3 | 36243803 | ||
| Pubmed | 4.73e-04 | 591 | 22 | 4 | 15231748 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 4.89e-04 | 1082 | 22 | 5 | 38697112 | |
| Pubmed | 5.16e-04 | 53 | 22 | 2 | 34026424 | ||
| Pubmed | 5.97e-04 | 57 | 22 | 2 | 21555454 | ||
| Pubmed | 6.31e-04 | 638 | 22 | 4 | 33239621 | ||
| Interaction | SIRT7 interactions | 6.71e-07 | 744 | 22 | 8 | int:SIRT7 | |
| Interaction | HERC2 interactions | 7.13e-07 | 503 | 22 | 7 | int:HERC2 | |
| Interaction | CIT interactions | 1.06e-05 | 1450 | 22 | 9 | int:CIT | |
| Interaction | HECTD1 interactions | 5.79e-05 | 984 | 22 | 7 | int:HECTD1 | |
| Interaction | RNF4 interactions | 7.48e-05 | 1412 | 22 | 8 | int:RNF4 | |
| Interaction | EED interactions | 8.81e-05 | 1445 | 22 | 8 | int:EED | |
| Interaction | CCDC65 interactions | 1.03e-04 | 14 | 22 | 2 | int:CCDC65 | |
| Interaction | LGR4 interactions | 1.70e-04 | 262 | 22 | 4 | int:LGR4 | |
| Interaction | NPM1 interactions | 2.02e-04 | 1201 | 22 | 7 | int:NPM1 | |
| Interaction | CUL7 interactions | 2.24e-04 | 845 | 22 | 6 | int:CUL7 | |
| Interaction | PPWD1 interactions | 2.45e-04 | 113 | 22 | 3 | int:PPWD1 | |
| Interaction | DHFR2 interactions | 2.47e-04 | 289 | 22 | 4 | int:DHFR2 | |
| Interaction | USP29 interactions | 3.09e-04 | 24 | 22 | 2 | int:USP29 | |
| Interaction | SF3B1 interactions | 3.17e-04 | 571 | 22 | 5 | int:SF3B1 | |
| Interaction | OBSL1 interactions | 3.18e-04 | 902 | 22 | 6 | int:OBSL1 | |
| Interaction | FUBP1 interactions | 3.19e-04 | 309 | 22 | 4 | int:FUBP1 | |
| Interaction | PARP1 interactions | 3.56e-04 | 1316 | 22 | 7 | int:PARP1 | |
| Interaction | BIRC3 interactions | 3.87e-04 | 1334 | 22 | 7 | int:BIRC3 | |
| Interaction | KLF8 interactions | 4.04e-04 | 329 | 22 | 4 | int:KLF8 | |
| Interaction | NRBP1 interactions | 4.12e-04 | 135 | 22 | 3 | int:NRBP1 | |
| GeneFamily | WD repeat domain containing | 1.47e-02 | 262 | 13 | 2 | 362 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 1.08e-05 | 363 | 22 | 5 | M41103 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_12H_BMDC_UP | 2.16e-05 | 200 | 22 | 4 | M3719 | |
| Coexpression | WHITFIELD_CELL_CYCLE_G1_S | 1.83e-04 | 133 | 22 | 3 | M2074 | |
| Coexpression | RICKMAN_METASTASIS_UP | 1.89e-04 | 350 | 22 | 4 | M9752 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 2.97e-04 | 394 | 22 | 4 | MM3724 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 3.39e-04 | 408 | 22 | 4 | M11891 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 3.61e-04 | 415 | 22 | 4 | MM1028 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 3.68e-04 | 417 | 22 | 4 | M39224 | |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN | 3.77e-04 | 170 | 22 | 3 | M6762 | |
| Coexpression | GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP | 3.77e-04 | 170 | 22 | 3 | M5657 | |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP | 3.84e-04 | 171 | 22 | 3 | M5655 | |
| Coexpression | ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP | 3.97e-04 | 173 | 22 | 3 | M2480 | |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN | 4.04e-04 | 174 | 22 | 3 | M6850 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 4.46e-04 | 180 | 22 | 3 | M8239 | |
| Coexpression | GARY_CD5_TARGETS_DN | 4.51e-04 | 440 | 22 | 4 | M13893 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_T_CELL_AGEING | 4.70e-04 | 445 | 22 | 4 | MM3853 | |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN | 4.90e-04 | 186 | 22 | 3 | M8175 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN | 5.97e-04 | 199 | 22 | 3 | M4523 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 5.97e-04 | 199 | 22 | 3 | M9124 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 5.97e-04 | 199 | 22 | 3 | M3070 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 6.06e-04 | 200 | 22 | 3 | M9889 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN | 6.06e-04 | 200 | 22 | 3 | M4529 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 6.09e-04 | 856 | 22 | 5 | M4500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 7.47e-07 | 795 | 22 | 8 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 8.94e-06 | 776 | 22 | 7 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 1.26e-05 | 818 | 22 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 1.58e-05 | 150 | 22 | 4 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 3.69e-05 | 186 | 22 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 4.00e-05 | 387 | 22 | 5 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 4.85e-05 | 403 | 22 | 5 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.85e-05 | 233 | 22 | 4 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.07e-04 | 90 | 22 | 3 | gudmap_developingGonad_P2_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 1.07e-04 | 778 | 22 | 6 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 1.16e-04 | 790 | 22 | 6 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 1.28e-04 | 804 | 22 | 6 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 1.30e-04 | 806 | 22 | 6 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.34e-04 | 97 | 22 | 3 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.34e-04 | 97 | 22 | 3 | gudmap_developingGonad_e18.5_epididymis_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.58e-04 | 271 | 22 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.68e-04 | 275 | 22 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | 1.79e-04 | 1241 | 22 | 7 | facebase_RNAseq_e10.5_MandArch_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 1.94e-04 | 1257 | 22 | 7 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.28e-04 | 298 | 22 | 4 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.35e-04 | 564 | 22 | 5 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.96e-04 | 127 | 22 | 3 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.10e-04 | 323 | 22 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.78e-04 | 138 | 22 | 3 | gudmap_developingGonad_e12.5_epididymis_k5_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 4.85e-04 | 1459 | 22 | 7 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.92e-04 | 151 | 22 | 3 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | 5.04e-04 | 1468 | 22 | 7 | facebase_RNAseq_e10.5_MandArch_2500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.44e-04 | 375 | 22 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | 5.71e-04 | 1060 | 22 | 6 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.01e-04 | 385 | 22 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | 6.13e-04 | 387 | 22 | 4 | gudmap_developingGonad_e16.5_ovary_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.30e-04 | 173 | 22 | 3 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | 9.75e-04 | 770 | 22 | 5 | gudmap_developingGonad_P2_ovary_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 9.87e-04 | 192 | 22 | 3 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.13e-03 | 201 | 22 | 3 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 1.14e-03 | 797 | 22 | 5 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 1.15e-03 | 799 | 22 | 5 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 1.16e-03 | 801 | 22 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | 1.20e-03 | 806 | 22 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 1.20e-03 | 806 | 22 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.25e-03 | 469 | 22 | 4 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 1.26e-03 | 815 | 22 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | 1.28e-03 | 818 | 22 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.28e-03 | 210 | 22 | 3 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | 1.37e-03 | 1252 | 22 | 6 | facebase_RNAseq_e10.5_MaxArch_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 1.49e-03 | 492 | 22 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.56e-03 | 225 | 22 | 3 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.58e-03 | 226 | 22 | 3 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.66e-03 | 230 | 22 | 3 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.99e-03 | 532 | 22 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.01e-03 | 246 | 22 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.05e-03 | 65 | 22 | 2 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500 | 2.05e-03 | 65 | 22 | 2 | gudmap_developingGonad_P2_ovary_500_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | 2.55e-03 | 1414 | 22 | 6 | facebase_RNAseq_e10.5_Emin_MedNas_2500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.99e-03 | 595 | 22 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.23e-03 | 291 | 22 | 3 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.39e-03 | 84 | 22 | 2 | gudmap_developingKidney_e15.5_Endothelial cells_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.65e-03 | 629 | 22 | 4 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.79e-08 | 197 | 22 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.55e-06 | 199 | 22 | 4 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.90e-05 | 135 | 22 | 3 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.77e-05 | 154 | 22 | 3 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 6.35e-05 | 159 | 22 | 3 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | FLU-Healthy-3|FLU / Virus stimulation, Condition and Cluster | 8.15e-05 | 173 | 22 | 3 | 32b8e5b400885dbeba57a7cb2c18d882664dc285 | |
| ToppCell | FLU-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 8.15e-05 | 173 | 22 | 3 | 26e89ac86922f1cd0100cf4d1cce37e74dd31c88 | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.58e-05 | 176 | 22 | 3 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | C_00|World / shred on cell type and cluster | 9.02e-05 | 179 | 22 | 3 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 22 | 3 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 22 | 3 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.11e-04 | 192 | 22 | 3 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.20e-04 | 197 | 22 | 3 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-04 | 198 | 22 | 3 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.22e-04 | 198 | 22 | 3 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.23e-04 | 199 | 22 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.23e-04 | 199 | 22 | 3 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.23e-04 | 199 | 22 | 3 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.25e-04 | 200 | 22 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.25e-04 | 200 | 22 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| Computational | Neighborhood of RBBP6 | 7.22e-05 | 70 | 13 | 3 | GNF2_RBBP6 | |
| Computational | Neighborhood of MAX | 6.16e-04 | 31 | 13 | 2 | GCM_MAX | |
| Drug | phenethyl isothiocyanate | 1.69e-06 | 401 | 22 | 6 | ctd:C058305 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.31e-05 | 177 | 22 | 4 | 985_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 2.42e-05 | 179 | 22 | 4 | 4585_DN | |
| Disease | disease progression measurement | 8.61e-04 | 61 | 21 | 2 | EFO_0008336 | |
| Disease | Malignant neoplasm of breast | 6.37e-03 | 1074 | 21 | 4 | C0006142 | |
| Disease | C-reactive protein measurement | 9.53e-03 | 1206 | 21 | 4 | EFO_0004458 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEVDEEKKMVEEAKV | 1131 | Q9UIG0 | |
| EEEEEKLEEEKEEKE | 776 | Q9P1Z9 | |
| QEKEEKREEPMEEEE | 591 | P49756 | |
| EEKEEEKKEKEEMEM | 301 | Q4G1C9 | |
| EREEEEEETQKEKME | 326 | Q4G1C9 | |
| ENEMREEKESKEEEK | 2266 | Q15751 | |
| EKMEEDNKEEEEKDH | 306 | Q96MG8 | |
| ALDMEKESEEKEEKE | 451 | Q9H307 | |
| DDDEVFEKKQKEMDE | 856 | Q04637 | |
| EDDEEEMEEKLAKAK | 586 | Q13206 | |
| EMKKKEEKEEEEEEE | 386 | Q5HYW3 | |
| EEKEEEEEEEMKQKE | 391 | Q5HYW3 | |
| EEEEEMKQKEEEEEI | 396 | Q5HYW3 | |
| EEEEEEEGEDKMKER | 911 | Q5TCS8 | |
| KEKKEEEKMEVDEAE | 846 | Q99460 | |
| EEKMEVDEAEKKEEK | 851 | Q99460 | |
| MDEDLEEELDEKDEK | 736 | O75592 | |
| MKMDKEEGDEDEEDE | 406 | Q76KP1 | |
| DGLAKEEEKKEEMEE | 1031 | Q96JN2 | |
| EEEKKEEMEEEKKQV | 1036 | Q96JN2 | |
| EKEEKEEELEEEEEK | 651 | Q9HAW4 | |
| EKMDEREKEKEKEEE | 321 | Q8NI27 | |
| EDEDKEKTFEEKEME | 3596 | Q15413 | |
| DDKEQDIADKMKEDE | 1116 | P55011 | |
| SEKEEEEEDKEMEEL | 1036 | P37275 | |
| EEEDKEMEELQEEKE | 1041 | P37275 | |
| EKEEVFEEKEEIMSE | 2301 | Q6ZQQ6 | |
| DEEEFMNEDEKEMKE | 1326 | Q86UW6 |